Alix Earle, a 25-year-old influencer and upcoming reality TV star, is expanding her investment portfolio with a new stake in liposomal supplement brand Cymbiotika, which is experiencing significant growth and projected to reach $150 million in revenue by 2025. Although the exact investment amount remains undisclosed, Earle joins a lineup of notable celebrity investors, including Kendall Jenner and Hailey Bieber.
Durana Elmi, cofounder and chief creative officer of Cymbiotika, praised Earle for her honest approach to wellness and her role as an investor shaping the brand’s future. Founded in San Diego in 2019, Cymbiotika specializes in flavored, single-serving liposomal supplements, with prices ranging from $48 to $88.
Earle emphasized the convenience and efficacy of Cymbiotika’s products, citing her personal use of their Glutathione, Colostrum, and vitamin C supplements. Beyond this investment, Earle has a successful track record, previously investing in brands like Poppi, SipMargs, and Gorgie.
Cymbiotika is also making strides in the retail space, having partnered with Target and Ulta Beauty, and recently completing a $25 million funding round with celebrity participation. The brand aims to enhance its omnichannel experience, ensuring that it meets consumers at every step of their wellness journey.
